Inflammation Research

, Volume 62, Issue 10, pp 911–917

Critical role of interleukin-5 in the development of a mite antigen-induced chronic bronchial asthma model

  • Hiroki Shimizu
  • Yasushi Obase
  • Shigeki Katoh
  • Keiji Mouri
  • Yoshihiro Kobashi
  • Mikio Oka
Original Research Paper


Objective and design

Asthma is associated with eosinophilic airway inflammation and characterized by enhanced airway sensitivity. Interleukin (IL)-5 plays an important role in the pathogenesis of asthma. The involvement of IL-5 receptor-mediated cellular signals in the pathogenesis of a mite antigen-induced chronic asthma model was investigated.


In this study, 48 female C57BL/6J (WT) mice and IL-5 receptor-deficient (IL-5RKO) mice were used.


Mite antigen (50 μl) was intranasally administered 13 times to WT and IL-5RKO mice.


Airway hypersensitivity (Mch PC200) and specific antigen exposure tests were performed, and lung tissue, bronchoalveolar lavage fluid (BALF), and blood were collected to investigate the asthma pathology and differences in the local pulmonary levels of cytokines and chemokines.


Airway sensitivity was enhanced and antigen-specific airway resistance was increased in WT mice. In addition, the number of eosinophils and Th2 cytokine levels in the BALF were increased. In contrast, IL-5RKO mice did not acquire the asthma pathology, such as antigen-specific airway resistance and eosinophilic airway inflammation. Mch PC200 was significantly correlated with cysteinyl leukotriene levels in WT mice.


These findings suggested that both IL-5 induced eosinophils and cysteinyl leukotrienes are involved in the pathology of this mite antigen-induced chronic asthma model.


Asthma Dermatophagoides farinae IL-5 IL-5 deficient mice Cysteinyl leukotrienes 


  1. 1.
    Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, Venge P, Ahlstedt S, Simony-Lafontaine J, Godard P, Michel F-B. Eosinophilic inflammation in asthma. N Engl J Med. 1990;323:1033–9.CrossRefGoogle Scholar
  2. 2.
    Bousquet JP, Jeffery K, Busse WW, Johnson M, Vignola AM. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med. 2000;161:1720–45.PubMedCrossRefGoogle Scholar
  3. 3.
    Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol. 2000;105:651–63.PubMedCrossRefGoogle Scholar
  4. 4.
    Weller PF. Human eosinophils. J Allergy Clin Immunol. 1997;100:283–7.PubMedCrossRefGoogle Scholar
  5. 5.
    Piacentini GL, Kaliner MA. The potential roles of leukotrienes in bronchial asthma. Am Rev Respir Dis. 1991;143:S96–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Reiss TF, Chervinsky P, Dockhorn RJ, Shingo S, Seidenberg B, Edwards TB, Montelukast Clinical Research Study Group. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Arch Intern Med. 1998;158:1213–20.PubMedCrossRefGoogle Scholar
  7. 7.
    Barnes N, Wei LX, Reiss TF, Leff JA, Shingo S, Yu C, Edelman JM. Analysis of montelukast in mild persistent asthmatic patients with near-normal lung function. Respir Med. 2001;95:379–86.PubMedCrossRefGoogle Scholar
  8. 8.
    Wardlaw AJ. Molecular basis for selective eosinophil trafficking in asthma: a multistep paradigm. J Allergy Clin Immunol. 1999;104:917–26.PubMedCrossRefGoogle Scholar
  9. 9.
    Leckie M, ten Brinke JA, Khan J, Diamant Z, O’Connor BJ, Walls CM, Mathur AK, Cowley HC, Chung KF, Djukanovic R, Hansel TT, Holgate ST, Sterk PJ, Barnes PJ. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet. 2000;356:2144–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Nair P, Pizzichini MM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, Hargreave FE, O’Byrne PM. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med. 2009;360:985–93.PubMedCrossRefGoogle Scholar
  11. 11.
    Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A, Marshall RP, Bradding P, Green RH, Wardlaw AJ, Pavord ID. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med. 2009;2009(360):973–84.CrossRefGoogle Scholar
  12. 12.
    Katoh S, Fukushima K, Matsumoto N, Matsumoto K, Abe K, Onai N, Matsushima K, Matsukura S. Accumulation of CCR4-expressing CD4+ T cells and high concentration of its ligands (TARC and MDC) in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia. Allergy. 2003;58:518–23.PubMedCrossRefGoogle Scholar
  13. 13.
    Katoh S, Fukushima K, Matsumoto N, Ehara N, Matsumoto K, Yamauchi A, Hirashima M. Accumulation of CXCR3-expressing eosinophils and increased concentration of its ligands (IP10 and Mig) in bronchoalveolar lavage fluid of patients with chronic eosinophilic pneumonia. Int Arch Allergy Immunol. 2005;137:229–35.PubMedCrossRefGoogle Scholar
  14. 14.
    Matsumoto N, Katoh S, Mukae H, Matsuo T, Takatsu K, Matsukura S. Critical role of IL-5 in antigen-induced pulmonary eosinophilia, but not in lymphocyte activation. Arch Allergy Immunol. 2003;130:209–15.CrossRefGoogle Scholar
  15. 15.
    Nials AT, Uddin S. Mouse models of allergic asthma: acute and chronic allergen challenge. Dis Model Mech. 2008;1:213–20.PubMedCrossRefGoogle Scholar
  16. 16.
    Katoh S, Kaminuma O, Hiroi T, Mori A, Ohtomo T, Maeda S, Shimizu H, Obase Y, Oka M. CD44 is critical for airway accumulation of antigen-specific Th2, but not Th1, cells induced by antigen challenge in mice. Eur J Immunol. 2011;41:3198–207.PubMedCrossRefGoogle Scholar
  17. 17.
    Coffey M, Peters-Golden M. Extending the understanding of leukotrienes in asthma. Curr Opin Allergy Clin Immunol. 2003;3:57–63.PubMedCrossRefGoogle Scholar
  18. 18.
    Lewis RA, Austen KF, Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med. 1990;323:645–55.PubMedCrossRefGoogle Scholar
  19. 19.
    Tanaka H, Kawada N, Yamada T, Kawada K, Takatsu K, Nagai H. Allergen-induced airway inflammation and bronchial responsiveness in interleukin-5 receptor alpha chain-deficient mice. Clin Exp Allergy. 2000;30:874–81.PubMedCrossRefGoogle Scholar
  20. 20.
    Fattouh R, Al-Garawi A, Fattouh M, Arias K, Walker TD, Goncharova S, Coyle AJ, Humbles AA, Jordana M. Eosinophils are dispensable for allergic remodeling and immunity in a model of house dust mite-induced airway disease. Am J Respir Crit Care Med. 2011;183:179–88.PubMedCrossRefGoogle Scholar
  21. 21.
    Walsh ER, Sahu N, Kearley J, Benjamin E, Kang BH, Humbles A, August A. Strain-specific requirement for eosinophils in the recruitment of T cells to the lung during the development of allergic asthma. J Exp Med. 2008;205:1285–92.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Basel 2013

Authors and Affiliations

  • Hiroki Shimizu
    • 1
  • Yasushi Obase
    • 1
  • Shigeki Katoh
    • 1
  • Keiji Mouri
    • 1
  • Yoshihiro Kobashi
    • 1
  • Mikio Oka
    • 1
  1. 1.Department of Respiratory MedicineKawasaki Medical SchoolKurashikiJapan

Personalised recommendations